全球神經修復與再生市場：依產品（神經調節裝置、導管、包紮物、保護器、移植物）、手術（神經修復[神經外修復、神經周圍修復]、移植[同種異體移植、異種移植]）、應用、最終用戶、裝置數量和地區分類－預測至2031年

預計神經修復和再生市場將從 2026 年的 80.6 億美元成長到 2031 年的 126.4 億美元，複合年成長率為 9.42%。

創傷性神經損傷、周邊神經損傷和神經系統疾病的發生率不斷上升，推動了對有效神經修復和功能恢復解決方案的需求。

隨著外科手術和再生醫學方法的不斷發展，醫院和專科醫療機構對創新神經移植物、神經導管、生物材料和神經刺激技術的需求日益成長。此外，組織工程、生物工程支架、神經再生技術和微創手術的進步正在改善治療效果並加速功能恢復。這些創新使醫療專業人員能夠更有效地處理複雜的神經損傷，從而推動了神經修復和再生市場的成長。

“單獨來看，神經刺激和神經調節療法預計將佔據神經修復和再生市場最大的佔有率。”

從手術類型來看，神經修復和再生市場可分為神經刺激和神經調控以及神經修復和再生兩大類。其中，神經刺激和神經調控領域佔據最大的市場佔有率，因為刺激療法在慢性疼痛、神經系統疾病及相關疾病的治療中廣泛應用。這些技術透過電刺激神經和神經通路，提供標靶治療性介入，有助於控制症狀並改善患者預後。此外，植入式和非侵入性刺激系統的日益普及、先進神經調控技術的不斷湧現以及臨床應用範圍的不斷擴大，持續推動著對這些手術的需求，使得神經刺激和神經調控成為該市場中最大的細分領域。

「預計醫院和門診手術中心（ASC）領域將佔據神經修復和再生市場最大的佔有率。”

全球神經修復和再生市場可按終端使用者細分為醫院和門診手術中心 (ASC)、專科診所和其他終端使用者。其中，醫院和門診手術中心佔據最大的市場佔有率。由於醫院和門診手術中心擁有專業的醫療團隊、先進的手術設施和完善的術後護理，它們仍然是神經修復、重組手術和神經刺激療法的主要施行地點。此外，隨著專業神經療法的日益普及、先進手術設備的廣泛應用以及人們對門診手術的偏好不斷增強，預計這些因素將繼續推動全球醫院和門診手術中心對神經修復和再生解決方案的需求。

“亞太地區：預計該地區在2026年至2031年期間，神經修復和再生市場將經歷最快的成長。”

全球神經修復和再生市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲五個地區。預計亞太地區在2026年至2031年間將達到最高的複合年成長率。在該地區，隨著專業醫療服務和手術能力的提升，對先進神經外科和重組手術的需求不斷成長。在中國，隨著醫療基礎設施的改善和對神經專科護理投入的增加，先進醫療技術的普及程度也不斷提高。在印度，不斷擴大的三級醫院、專科診所和手術中心網路正在推動神經修復、再生和神經調控技術的應用。同時，在日本，人口老化以及對神經系統疾病和疼痛管理療法的需求不斷成長，持續推動全部區域神經修復和再生市場的發展。

Medtronic plc（愛爾蘭）、Boston Scientific Corporation（英國）、Axogen Corporation（英國）、Baxter（英國）、Integra LifeSciences Corporation（英國）、NeuroPace, Inc.（英國）、Bioventus Inc.（英國）、Abbott Laboratories（英國）、LivaNova PLC（英國）和美國再生市場（美國）修復公司（英國）和美國的神經市場之一。

調查範圍：

本研究報告按產品類型（神經刺激/神經調節、生物材料產品）、手術類型（神經刺激/神經調節、神經修復和再生）、應用類型（周圍神經損傷、脊髓損傷、神經病變疼痛、神經神經退化性疾病、顱神經疾病、泌尿系統和盆腔神經疾病、整形外科和運動相關神經損傷以及其他應用）、最終用戶類型（醫院和門診手術中心(ASC)、專科診所和其他最終用戶）以及地區類型（北美、歐洲、亞太地區、拉丁美洲以及中東和非洲）對神經修復和再生市場進行了細分。

本報告詳細闡述了影響神經修復和再生市場成長的關鍵因素，包括促進因素、限制因素、機會和挑戰。透過對主要行業參與者的深入分析，報告揭示了他們的業務概況、解決方案、收購、協議、關鍵策略（例如產品發布）以及神經修復和再生市場的最新發展。此外，該報告還對神經修復和再生市場生態系統中的新興企業進行了競爭分析。

購買本報告的理由：

本報告透過提供神經修復和再生市場整體及各細分市場最準確的銷售估算，幫助市場領導和新參與企業更了解市場。報告也幫助相關人員了解競爭格局，更好地定位自身業務，並獲取制定合適打入市場策略的洞察。此外，報告還幫助相關人員掌握市場趨勢，並提供關鍵市場促進因素、阻礙因素、機會和挑戰的資訊。

本報告深入分析了以下幾點：

• 本分析探討了影響神經修復和再生市場成長的因素，包括主要促進因素（神經系統疾病和神經損傷的盛行率上升、老年人口增加以及相關的神經系統疾病盛行率上升、政府支持和資金支持以及先進的醫療基礎設施，以及先進的神經調節和神經刺激技術的發展）、阻礙因素（傾向於選擇藥物療法而不是神經調節產品）、機會（新興經濟體大規模的患者群體和不斷成長的醫療保健投資，以及神經修復和再生技術的臨床應用不斷擴大）和挑戰（神經修復和再生產品嚴格的法規結構和耗時的核准流程，以及訓練有素的專業人員短缺）。
• 產品開發/創新：深入了解神經修復和再生市場的未來技術、研發活動和新產品發布。
• 市場發展：盈利市場的全面資訊－本報告分析了各個地區的神經修復和再生市場。
• 市場多元化：全面介紹神經修復和再生市場的新產品、未開發的市場、近期趨勢和投資情況。
• 競爭分析：對美敦力公司（愛爾蘭）、波士頓科學公司（美國）、Axogen公司（美國）、百特公司（美國）、Integra LifeSciences公司（美國）、NeuroPace公司（美國）、Bioventus公司（美國）、雅培實驗室（美國）、LivaNova公司（英國）和Neuronetics公司（美國）等主要公司的市場佔有率和市場佔有率。

目錄

The nerve repair & regeneration market is projected to grow from USD 8.06 billion in 2026 to USD 12.64 billion by 2031, at a CAGR of 9.42%. The increasing incidence of traumatic nerve injuries, peripheral nerve damage, and neurological disorders is driving demand for effective nerve repair and functional restoration solutions.

As surgical and regenerative approaches continue to advance, the need for innovative nerve grafts, conduits, biomaterials, and neurostimulation technologies is expanding across hospitals and specialty care settings. Furthermore, advancements in tissue engineering, bioengineered scaffolds, nerve regeneration techniques, and minimally invasive procedures are improving treatment outcomes and supporting faster functional recovery. These innovations enable healthcare providers to address complex nerve injuries more effectively, supporting growth in the nerve repair & regeneration market.

"The Neurostimulation and Neuromodulation segment is expected to account for the largest share of the nerve repair and regeneration market, by procedure."

Based on procedure, the nerve repair and regeneration market is segmented into neurostimulation & neuromodulation and nerve repair & regeneration. The neurostimulation & neuromodulation segment accounts for the largest market share because stimulation-based therapies are established for managing chronic pain, neurological disorders, and nerve-related conditions. These technologies provide targeted therapeutic interventions through electrical stimulation of nerves or neural pathways, supporting symptom management and improved patient outcomes. Additionally, the increasing adoption of implantable and non-invasive stimulation systems, growing availability of advanced neuromodulation technologies, and expanding clinical applications continue to support demand for these procedures, making neurostimulation and neuromodulation the largest segment within the market.

"The Hospitals and Ambulatory Surgical Centers segment is expected to account for the largest share of the nerve repair and regeneration market."

The global nerve repair and regeneration market can be segmented by end user into hospitals and ambulatory surgical centers (ASCs), specialty clinics, and other end users. Among these, the hospitals and ASCs segment accounted for the largest market share. Hospitals and ASCs remain the primary settings for nerve repair, reconstructive procedures, and neurostimulation interventions due to the availability of specialized surgical teams, advanced operating facilities, and comprehensive postoperative care. Furthermore, the increasing adoption of specialized nerve treatment procedures, the availability of advanced surgical equipment, and the growing preference for outpatient interventions are expected to support continued use of nerve repair and regeneration solutions across hospitals and ASCs worldwide.

"Asia Pacific: The fastest-growing market for nerve repair and regeneration from 2026 to 2031"

The global nerve repair and regeneration market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to grow at the highest regional CAGR from 2026 to 2031. The region is witnessing increasing demand for advanced neurological and reconstructive procedures, supported by improvements in specialized healthcare services and surgical capabilities. China is expanding access to advanced medical technologies through healthcare infrastructure development and increasing investments in specialized neurological care. India's growing network of tertiary-care hospitals, specialty clinics, and surgical centers is supporting the adoption of nerve repair, regeneration, and neuromodulation technologies. Meanwhile, Japan's aging population and increasing demand for neurological and pain management therapies continue to support the expansion of the nerve repair and regeneration market across the region.

The breakdown of the profile of primary participants in the nerve repair and regeneration market:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level Executives - 27%, Directors - 18%, and Others - 55%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa - 4%

Medtronic plc (Ireland), Boston Scientific Corporation (US), Axogen Corporation (US), Baxter (US), Integra LifeSciences Corporation (US), NeuroPace, Inc. (US), Bioventus Inc. (US), Abbott Laboratories (US), LivaNova PLC (UK), and Neuronetics, Inc. (US) are among the key players operating in the nerve repair and regeneration market.

Research Coverage:

This research report categorizes the nerve repair and regeneration market by product (neurostimulation & neuromodulation, biomaterial-based products), by procedure (neurostimulation & neuromodulation and nerve repair & regeneration), by application (peripheral nerve injuries, spinal cord injuries, neuropathic pain, neurodegenerative disorders, cranial nerve disorders, urological & pelvic nerve disorders, orthopedic & sports-related nerve injuries and other applications), by end user (hospitals & ASCs, specialty clinics, other end users), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa).

The report covers detailed information on major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the nerve repair and regeneration market. A detailed analysis of key industry players provides insights into their business overview, solutions, key strategies such as acquisitions, agreements, and product launches, and recent developments in the nerve repair and regeneration market. This report covers a competitive analysis of upcoming startups in the nerve repair and regeneration market ecosystem.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall repair and regeneration market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (rising prevalence of neurological disorders and nerve injuries, rising geriatric population and the subsequent increase in the prevalence of neurological disorders, favorable government support and funding with advanced healthcare infrastructure, development of advanced neuromodulation and neurostimulation technologies), restraints (preference for drug therapies over neuromodulation products), opportunities (large patient population and rising healthcare investments in emerging economies, expanding clinical applications of nerve repair and regeneration technologies), and challenges (stringent regulatory framework and time-consuming approval processes for nerve repair and regeneration products, shortage of trained professionals) influencing the growth of the nerve repair and regeneration market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the nerve repair and regeneration market
• Market Development: Comprehensive information about lucrative markets-the report analyzes the nerve repair and regeneration market across varied regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nerve repair and regeneration market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Medtronic plc (Ireland), Boston Scientific Corporation (US), Axogen Corporation (US), Baxter (US), Integra LifeSciences Corporation (US), NeuroPace, Inc. (US), Bioventus Inc. (US), Abbott Laboratories (US), LivaNova PLC (UK), and Neuronetics, Inc. (US)

TABLE OF CONTENTS

• TABLE 1 KEY MOVES & STRATEGIC FOCUS
• TABLE 2 NERVE REPAIR & REGENERATION MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 3 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023-2030
• TABLE 4 NORTH AMERICA: MACROECONOMIC INDICATORS
• TABLE 5 EUROPE: MACROECONOMIC INDICATORS
• TABLE 6 ASIA PACIFIC: MACROECONOMIC INDICATORS
• TABLE 7 LATIN AMERICA: MACROECONOMIC INDICATORS
• TABLE 8 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
• TABLE 9 NERVE REPAIR & REGENERATION MARKET: ROLE OF COMPANIES IN ECOSYSTEM
• TABLE 10 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY KEY PLAYER, 2024-2026 (USD)
• TABLE 11 AVERAGE SELLING PRICE TREND OF NERVE REPAIR & REGENERATION PRODUCTS, BY REGION, 2024-2026 (USD)
• TABLE 12 IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
• TABLE 13 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
• TABLE 14 NERVE REPAIR & REGENERATION MARKET: KEY CONFERENCES & EVENTS, 2026-2027
• TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
• TABLE 16 KEY PATENTS IN NERVE REPAIR & REGENERATION MARKET, 2022-2026
• TABLE 17 KEY COMPANIES IMPLEMENTING AI IN NERVE REPAIR & REGENERATION MARKET
• TABLE 18 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
• TABLE 19 NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA) MEDICAL DEVICES CLASSIFICATION
• TABLE 20 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
• TABLE 21 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 22 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 23 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 24 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%)
• TABLE 27 KEY BUYING CRITERIA, BY END USER
• TABLE 28 ADOPTION BARRIERS & INTERNAL CHALLENGES
• TABLE 29 NERVE REPAIR & REGENERATION MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES
• TABLE 30 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 31 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 32 SPINAL CORD STIMULATION DEVICES OFFERED BY KEY PLAYERS
• TABLE 33 NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 34 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 35 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 36 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 37 DEEP BRAIN STIMULATION DEVICES OFFERED BY KEY PLAYERS
• TABLE 38 NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 39 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 40 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 41 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DEEP BRAIN STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 42 VAGUS NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
• TABLE 43 NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 44 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 45 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 46 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR VAGUS NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 47 SACRAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
• TABLE 48 NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 49 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 50 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 51 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 52 GASTRIC NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
• TABLE 53 NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 54 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 55 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 56 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR GASTRIC NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 57 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES OFFERED BY KEY PLAYERS
• TABLE 58 NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 59 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 60 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 61 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 62 TRANSCRANIAL MAGNETIC STIMULATION DEVICES OFFERED BY KEY PLAYERS
• TABLE 63 NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 64 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 65 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 66 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR TRANSCRANIAL MAGNETIC STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 67 RESPIRATORY ELECTRICAL STIMULATION DEVICES OFFERED BY KEY PLAYERS
• TABLE 68 NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 69 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 70 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 71 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR RESPIRATORY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 72 OTHER STIMULATION DEVICES OFFERED BY KEY PLAYERS
• TABLE 73 NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 74 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 75 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 76 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER STIMULATION DEVICES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 77 NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 78 NERVE CONDUITS OFFERED BY SOME MARKET PLAYERS
• TABLE 79 NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 80 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 81 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 82 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE CONDUITS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 83 NERVE GRAFTS OFFERED BY SOME MARKET PLAYERS
• TABLE 84 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 85 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 86 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 87 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 88 NERVE WRAPS OFFERED BY SOME MARKET PLAYERS
• TABLE 89 NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 90 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 91 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 92 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE WRAPS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 93 NERVE PROTECTORS OFFERED BY SOME MARKET PLAYERS
• TABLE 94 NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 95 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 96 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 97 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE PROTECTORS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 98 GLOBAL NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (NUMBER OF DEVICES)
• TABLE 99 NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 100 NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 101 NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 102 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 103 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 104 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR INTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 105 NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 106 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 107 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 108 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR EXTERNAL NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 109 NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 110 NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 111 NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 112 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 113 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 114 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 115 NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 116 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 117 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 118 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR EPINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 119 NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 120 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 121 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 122 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR PERINEURAL REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 123 NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 124 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 125 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 126 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR GROUP FASCICULAR REPAIR PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 127 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 128 NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 129 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 130 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 131 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GRAFTING PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 132 NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 133 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 134 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 135 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR ALLOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 136 NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 137 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 138 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 139 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR XENOGRAFTS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 140 NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 141 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 142 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 143 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE GUIDANCE & PROTECTION PROCEDURES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 144 NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 145 NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 146 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 147 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 148 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR PERIPHERAL NERVE INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 149 NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 150 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, 2024-2031 (USD MILLION)
• TABLE 151 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 152 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPINAL CORD INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 153 NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY REGION, 2024-2031 (USD MILLION)
• TABLE 154 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 155 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 156 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROPATHIC PAIN, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 157 NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 158 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, 2024-2031 (USD MILLION)
• TABLE 159 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 160 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 161 NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 162 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, 2024-2031 (USD MILLION)
• TABLE 163 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 164 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR CRANIAL NERVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 165 NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 166 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, 2024-2031 (USD MILLION)
• TABLE 167 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 168 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR UROLOGICAL & PELVIC NERVE DISORDERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 169 NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY REGION, 2024-2031 (USD MILLION)
• TABLE 170 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, 2024-2031 (USD MILLION)
• TABLE 171 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 172 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR ORTHOPEDIC & SPORTS-RELATED NERVE INJURIES, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 173 NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 174 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, 2024-2031 (USD MILLION)
• TABLE 175 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 176 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 177 NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 178 NUMBER OF HOSPITALS PER CAPITA, BY COUNTRY, 2026
• TABLE 179 NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 180 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 181 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 182 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 183 NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 184 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 185 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 186 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 187 NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
• TABLE 188 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, 2024-2031 (USD MILLION)
• TABLE 189 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 190 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 191 NERVE REPAIR & REGENERATION MARKET, BY REGION, 2024-2031 (USD MILLION)
• TABLE 192 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 193 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 194 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 195 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 196 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 197 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 198 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 199 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 200 NORTH AMERICA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 201 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 202 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 203 COMPANY PRODUCTS THAT RECEIVED APPROVAL IN US
• TABLE 204 US: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 205 US: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 206 US: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 207 US: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 208 US: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 209 US: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 210 US: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 211 US: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 212 US: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 213 US: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)

List of Tables

• TABLE 214 CANADA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 215 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 216 CANADA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 217 CANADA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 218 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 219 CANADA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 220 CANADA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 221 CANADA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 222 CANADA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 223 CANADA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 224 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 225 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 226 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 227 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 228 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 229 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 230 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 231 EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 232 EUROPE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 233 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 234 EUROPE: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 235 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 236 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 237 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 238 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 239 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 240 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 241 GERMANY: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 242 GERMANY: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 243 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 244 GERMANY: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 245 UK: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 246 UK: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 247 UK: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 248 UK: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 249 UK: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 250 UK: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 251 UK: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 252 UK: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 253 UK: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 254 UK: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 255 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 256 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 257 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 258 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 259 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 260 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 261 FRANCE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 262 FRANCE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 263 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 264 FRANCE: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 265 ITALY: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 266 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 267 ITALY: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 268 ITALY: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 269 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 270 ITALY: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 271 ITALY: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 272 ITALY: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 273 ITALY: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 274 ITALY: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 275 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 276 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 277 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 278 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 279 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 280 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 281 SPAIN: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 282 SPAIN: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 283 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 284 SPAIN: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 285 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 286 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 287 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 288 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 289 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 290 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 291 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 292 REST OF EUROPE: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 293 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 294 REST OF EUROPE: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 295 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 296 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 297 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 298 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 299 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 300 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 301 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 302 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 303 ASIA PACIFIC: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 304 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 305 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 306 CHINA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 307 CHINA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 308 CHINA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 309 CHINA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 310 CHINA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 311 CHINA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 312 CHINA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 313 CHINA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 314 CHINA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 315 CHINA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 316 JAPAN: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 317 JAPAN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 318 JAPAN: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 319 JAPAN: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 320 JAPAN: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 321 JAPAN: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 322 JAPAN: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 323 JAPAN: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 324 JAPAN: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 325 JAPAN: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 326 INDIA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 327 INDIA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 328 INDIA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 329 INDIA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 330 INDIA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 331 INDIA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 332 INDIA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 333 INDIA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 334 INDIA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 335 INDIA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 336 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 337 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 338 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 339 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 340 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 341 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 342 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 343 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 344 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 345 REST OF ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 346 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 347 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 348 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 349 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 350 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 351 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 352 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 353 LATIN AMERICA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 354 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 355 LATIN AMERICA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 356 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
• TABLE 357 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION DEVICES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 358 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET FOR BIOMATERIALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 359 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET, BY PROCEDURE, 2024-2031 (USD MILLION)
• TABLE 360 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 361 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET FOR NERVE REPAIR & REGENERATION PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 362 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 363 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION PRODUCT MARKET FOR NERVE GRAFTING PROCEDURES, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 364 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 365 MIDDLE EAST & AFRICA: NERVE REPAIR & REGENERATION MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 366 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN NERVE REPAIR & REGENERATION MARKET, JANUARY 2023-AUGUST 2026
• TABLE 367 NERVE REPAIR & REGENERATION MARKET: DEGREE OF COMPETITION
• TABLE 368 NERVE REPAIR & REGENERATION MARKET: REGION FOOTPRINT
• TABLE 369 NERVE REPAIR & REGENERATION MARKET: PRODUCT FOOTPRINT
• TABLE 370 NERVE REPAIR & REGENERATION MARKET: PROCESS FOOTPRINT
• TABLE 371 NERVE REPAIR & REGENERATION MARKET: END-USER FOOTPRINT
• TABLE 372 NERVE REPAIR & REGENERATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 373 NERVE REPAIR & REGENERATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
• TABLE 374 NERVE REPAIR & REGENERATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
• TABLE 375 NERVE REPAIR & REGENERATION MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023- AUGUST 2026
• TABLE 376 NERVE REPAIR & REGENERATION MARKET: DEALS, JANUARY 2023-JULY 2026
• TABLE 377 MEDTRONIC: COMPANY OVERVIEW
• TABLE 378 MEDTRONIC: PRODUCTS OFFERED
• TABLE 379 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2023-AUGUST 2026
• TABLE 380 MEDTRONIC: DEALS, JANUARY 2023-AUGUST 2026
• TABLE 381 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
• TABLE 382 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
• TABLE 383 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS, JANUARY 2023-AUGUST 2026
• TABLE 384 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2023-AUGUST 2026
• TABLE 385 ABBOTT: COMPANY OVERVIEW
• TABLE 386 ABBOTT: PRODUCTS OFFERED
• TABLE 387 ABBOTT: PRODUCT APPROVALS, JANUARY 2023-AUGUST 2026
• TABLE 388 LIVANOVA PLC: COMPANY OVERVIEW
• TABLE 389 LIVANOVA PLC: PRODUCTS OFFERED
• TABLE 390 LIVANOVA PLC: PRODUCT LAUNCHES, JANUARY 2023-AUGUST 2026
• TABLE 391 AXOGEN CORPORATION: COMPANY OVERVIEW
• TABLE 392 AXOGEN CORPORATION: PRODUCTS OFFERED
• TABLE 393 AXOGEN CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-AUGUST 2026
• TABLE 394 NEUROPACE, INC.: COMPANY OVERVIEW
• TABLE 395 NEUROPACE, INC.: PRODUCTS OFFERED
• TABLE 396 BIOVENTUS: COMPANY OVERVIEW
• TABLE 397 BIOVENTUS: PRODUCTS OFFERED
• TABLE 398 BIOVENTUS: PRODUCT APPROVALS, JANUARY 2023-AUGUST 2026
• TABLE 399 BAXTER: COMPANY OVERVIEW
• TABLE 400 BAXTER: PRODUCTS OFFERED
• TABLE 401 BAXTER: DEALS, JANUARY 2023-AUGUST 2026
• TABLE 402 NEURONETICS: COMPANY OVERVIEW
• TABLE 403 NEURONETICS: PRODUCTS OFFERED
• TABLE 404 NEURONETICS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-AUGUST 2026
• TABLE 405 NEURONETICS: DEALS, JANUARY 2023-AUGUST 2026
• TABLE 406 INTEGRA LIFESCIENCES: COMPANY OVERVIEW
• TABLE 407 INTEGRA LIFESCIENCES: PRODUCTS OFFERED
• TABLE 408 ELECTROCORE, INC.: COMPANY OVERVIEW
• TABLE 409 ELECTROCORE, INC.: PRODUCTS OFFERED
• TABLE 410 ELECTROCORE, INC.: PRODUCT LAUNCHES, JANUARY 2023-AUGUST 2026
• TABLE 411 ELECTROCORE, INC.: DEALS, JANUARY 2023-AUGUST 2026
• TABLE 412 NEUROSIGMA, INC.: COMPANY OVERVIEW
• TABLE 413 SOTERIX MEDICAL INC.: COMPANY OVERVIEW
• TABLE 414 SYNAPSE BIOMEDICAL INC.: COMPANY OVERVIEW
• TABLE 415 ALEVA NEUROTHERAPEUTICS: COMPANY OVERVIEW
• TABLE 416 THERANICA BIO-ELECTRONICS LTD.: COMPANY OVERVIEW
• TABLE 417 GIMER MEDICAL: COMPANY OVERVIEW
• TABLE 418 REGENITY BIOSCIENCES: COMPANY OVERVIEW
• TABLE 419 CHECKPOINT SURGICAL, INC.: COMPANY OVERVIEW
• TABLE 420 RENISHAW PLC: COMPANY OVERVIEW
• TABLE 421 TVNS TECHNOLOGIES GMBH: COMPANY OVERVIEW
• TABLE 422 BIOWAVE: COMPANY OVERVIEW
• TABLE 423 BIOTRONIK: COMPANY OVERVIEW
• TABLE 424 SALUDA MEDICAL PTY LTD.: COMPANY OVERVIEW
• TABLE 425 ALAFAIR BIOSCIENCES, INC.: COMPANY OVERVIEW
• TABLE 426 NERVE REPAIR & REGENERATIVE MARKET: RISK ASSESSMENT

List of Figures

• FIGURE 1 NERVE REPAIR & REGENERATION MARKET SEGMENTATION & REGIONAL SCOPE
• FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS
• FIGURE 3 GLOBAL NERVE REPAIR & REGENERATION MARKET, 2024-2031
• FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NERVE REPAIR & REGENERATION MARKET, 2023-2025
• FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF NERVE REPAIR & REGENERATION MARKET
• FIGURE 6 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN NERVE REPAIR & REGENERATION MARKET, 2025
• FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 8 RISING CASES OF NEUROLOGICAL DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
• FIGURE 9 NEUROSTIMULATION & NEUROMODULATION DEVICES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 10 NEUROSTIMULATION & NEUROMODULATION PROCEDURES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
• FIGURE 11 PERIPHERAL NERVE INJURIES SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
• FIGURE 12 HOSPITALS & ASCS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
• FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 14 NERVE REPAIR & REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 15 NERVE REPAIR & REGENERATION MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 16 NERVE REPAIR & REGENERATION MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 17 NERVE REPAIR & REGENERATION MARKET: VALUE CHAIN ANALYSIS
• FIGURE 18 NERVE REPAIR & REGENERATION MARKET: ECOSYSTEM ANALYSIS
• FIGURE 19 NERVE REPAIR & REGENERATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• FIGURE 20 NUMBER OF DEALS & FUNDING ACTIVITIES IN NERVE REPAIR & REGENERATION MARKET
• FIGURE 21 PATENT ANALYSIS FOR NERVE REPAIR & REGENERATION, JANUARY 2016-DECEMBER 2025
• FIGURE 22 MARKET POTENTIAL OF AI IN NERVE REPAIR & REGENERATION MARKET
• FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
• FIGURE 24 KEY BUYING CRITERIA, BY END USER
• FIGURE 25 NORTH AMERICA: NERVE REPAIR & REGENERATION MARKET SNAPSHOT
• FIGURE 26 NUMBER OF PATIENTS WITH ALZHEIMER'S IN US, 2020-2060 (MILLION)
• FIGURE 27 ASIA PACIFIC: NERVE REPAIR & REGENERATION MARKET SNAPSHOT
• FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN NERVE REPAIR & REGENERATION MARKET, 2023-2025 (USD MILLION)
• FIGURE 29 NERVE REPAIR & REGENERATION MARKET SHARE ANALYSIS, 2025 (GLOBAL)
• FIGURE 30 NERVE REPAIR & REGENERATION MARKET SHARE ANALYSIS, 2025 (US)
• FIGURE 31 NERVE REPAIR & REGENERATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
• FIGURE 32 NERVE REPAIR & REGENERATION MARKET: COMPANY FOOTPRINT
• FIGURE 33 NERVE REPAIR & REGENERATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
• FIGURE 34 EV/EBITDA OF KEY VENDORS
• FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 36 NERVE REPAIR & REGENERATION MARKET: BRAND/PRODUCT COMPARISON FOR NERVE REPAIR & REGENERATION
• FIGURE 37 MEDTRONIC: COMPANY SNAPSHOT (2025)
• FIGURE 38 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025)
• FIGURE 39 ABBOTT: COMPANY SNAPSHOT (2025)
• FIGURE 40 LIVANOVA PLC: COMPANY SNAPSHOT (2025)
• FIGURE 41 AXOGEN CORPORATION: COMPANY SNAPSHOT (2025)
• FIGURE 42 NEUROPACE, INC.: COMPANY SNAPSHOT
• FIGURE 43 BIOVENTUS: COMPANY SNAPSHOT (2025)
• FIGURE 44 BAXTER: COMPANY SNAPSHOT (2025)
• FIGURE 45 NEURONETICS: COMPANY SNAPSHOT (2025)
• FIGURE 46 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2025)
• FIGURE 47 ELECTROCORE, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 48 RESEARCH DESIGN
• FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 50 TOP-DOWN APPROACH
• FIGURE 51 DATA TRIANGULATION